Cargando…

Genetic variation in glutamatergic genes moderates the effects of childhood adversity on brain volume and IQ in treatment-resistant schizophrenia

Detalles Bibliográficos
Autores principales:	Mohamed Saini, Suriati, Bousman, Chad A., Mancuso, Serafino G., Cropley, Vanessa, Van Rheenen, Tamsyn E., Lenroot, Rhoshel K., Bruggemann, Jason, Weickert, Cynthia S., Weickert, Thomas W., Sundram, Suresh, Everall, Ian P., Pantelis, Christos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502098/ https://www.ncbi.nlm.nih.gov/pubmed/37709784 http://dx.doi.org/10.1038/s41537-023-00381-w

Ejemplares similares

The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes
por: Wells, Ruth, et al.
Publicado: (2015)

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Perturbed iron biology in the prefrontal cortex of people with schizophrenia
por: Lotan, Amit, et al.
Publicado: (2023)

S187. EXPLORING NEURODEVELOPMENTAL AND FAMILIAL ORIGINS OF NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA
por: Cooper, Rebecca, et al.
Publicado: (2020)

Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia
por: Bousman, Chad A., et al.
Publicado: (2019)

T157. FRONTOSTRIATAL CONNECTIVITY IN TREATMENT-RESISTANT SCHIZOPHRENIA: RELATIONSHIP TO POSITIVE SYMPTOMS AND COGNITIVE FLEXIBILITY
por: Cropley, Vanessa, et al.
Publicado: (2018)

F192. SYSTEMATIC META-ANALYSIS IDENTIFIES FIVE NOVEL ASSOCIATION LOCI FOR SCHIZOPHRENIA
por: Liu, Chenxing, et al.
Publicado: (2018)

Testosterone Is Inversely Related to Brain Activity during Emotional Inhibition in Schizophrenia
por: Vercammen, Ans, et al.
Publicado: (2013)

O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS
por: Cropley, Vanessa, et al.
Publicado: (2018)

Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2015)

M62. PERIPHERAL INFLAMMATION MARKERS IDENTIFY SUBSET OF PATIENTS WITH SCHIZOPHRENIA AND RELATED PSYCHOSES WHO HAVE INTELLECTUAL DECLINE FROM PREMORBID LEVELS
por: Weickert, Thomas, et al.
Publicado: (2020)

C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
por: Jacomb, Isabella, et al.
Publicado: (2018)

Interrogating the Evolutionary Paradox of Schizophrenia: A Novel Framework and Evidence Supporting Recent Negative Selection of Schizophrenia Risk Alleles
por: Liu, Chenxing, et al.
Publicado: (2019)

Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia
por: Mostaid, M S, et al.
Publicado: (2017)

Dysregulation of kynurenine metabolism is related to proinflammatory cytokines, attention, and prefrontal cortex volume in schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2019)

Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume
por: Fillman, S G, et al.
Publicado: (2016)

Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
por: Boerrigter, Danny, et al.
Publicado: (2017)

Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk
por: Saini, S M, et al.
Publicado: (2017)

Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia
por: Skilleter, A. J., et al.
Publicado: (2015)

S165. GLUTAMATERGIC ABNORMALITIES IN EARLY SCHIZOPHRENIA AND BIPOLAR DISORDER MEASURED USING WHOLE-BRAIN SPECTROSCOPY
por: Lenroot, Rhoshel, et al.
Publicado: (2020)

The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies
por: Liu, Chenxing, et al.
Publicado: (2019)

Common polymorphisms in dopamine-related genes combine to produce a ‘schizophrenia-like' prefrontal hypoactivity
por: Vercammen, A, et al.
Publicado: (2014)

Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls
por: Fullerton, Janice M., et al.
Publicado: (2018)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
por: Weickert, Thomas W., et al.
Publicado: (2017)

15. ON THE ROAD TO CURING SCHIZOPHRENIA
por: Weickert, Cynthia Shannon
Publicado: (2018)

Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia
por: Weickert, Thomas W., et al.
Publicado: (2016)

Mismatch negativity (MMN) and sensory auditory processing in children aged 9–12 years presenting with putative antecedents of schizophrenia()
por: Bruggemann, Jason M., et al.
Publicado: (2013)

Biomarkers in Schizophrenia: A Brief Conceptual Consideration
por: Weickert, Cynthia S., et al.
Publicado: (2013)

Glutamatergic hypo-function in the left superior and middle temporal gyri in early schizophrenia: a data-driven three-dimensional proton spectroscopic imaging study
por: Bustillo, Juan R., et al.
Publicado: (2020)

Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia
por: Ji, E, et al.
Publicado: (2016)

Schizophrenia genetics in the genome-wide era: a review of Japanese studies
por: Kanazawa, Tetsufumi, et al.
Publicado: (2017)

Brain Morphological Characteristics of Cognitive Subgroups of Schizophrenia-Spectrum Disorders and Bipolar Disorder: A Systematic Review with Narrative Synthesis
por: Karantonis, James A., et al.
Publicado: (2022)

Correction to: Brain Morphological Characteristics of Cognitive Subgroups of Schizophrenia‑spectrum Disorders and Bipolar Disorder: a Systematic Review with Narrative Synthesis
por: Karantonis, James A., et al.
Publicado: (2022)

Disambiguating ventral striatum fMRI-related bold signal during reward prediction in schizophrenia
por: Morris, R W, et al.
Publicado: (2012)

F158. FUNCTIONAL CONNECTIVITY DIVERSITY OF THE INSULA CORTEX IN SCHIZOPHRENIA: SUBREGIONS OR CONTINUA?
por: Tian, Ye, et al.
Publicado: (2018)

Brain antibodies in the cortex and blood of people with schizophrenia and controls
por: Glass, L J, et al.
Publicado: (2017)

Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
por: Catts, Vibeke Sørensen, et al.
Publicado: (2012)

F15. DIFFERENTIAL EXPRESSION PATTERNS OF EPIDERMAL GROWTH FACTOR (EGF) AND IMMUNE SYSTEM MARKERS IN DORSOLATERAL PREFRONTAL (BA46) AND ORBITOFRONTAL (BA11) CORTICES IN SCHIZOPHRENIA AND MOOD DISORDER
por: Ketharanathan, Tharini, et al.
Publicado: (2018)

Cell proliferation is reduced in the hippocampus in schizophrenia
por: Allen, Katherine M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r74pls8g8fgio3bakqfkb2c777